Berberine-INF55 (5-nitro-2-phenylindole) hybrid antimicrobials: effects of varying the relative orientation of the berberine and INF55 components.

MLA

Tomkiewicz, Danuta, et al. “Berberine-INF55 (5-Nitro-2-Phenylindole) Hybrid Antimicrobials: Effects of Varying the Relative Orientation of the Berberine and INF55 Components.” Antimicrobial Agents and Chemotherapy, vol. 54, no. 8, Aug. 2010, pp. 3219–24. EBSCOhost, https://doi.org/10.1128/AAC.01715-09.

APA

Tomkiewicz, D., Casadei, G., Larkins-Ford, J., Moy, T. I., Garner, J., Bremner, J. B., Ausubel, F. M., Lewis, K., & Kelso, M. J. (2010). Berberine-INF55 (5-nitro-2-phenylindole) hybrid antimicrobials: effects of varying the relative orientation of the berberine and INF55 components. Antimicrobial Agents and Chemotherapy, 54(8), 3219–3224. https://doi.org/10.1128/AAC.01715-09

Chicago

Tomkiewicz, Danuta, Gabriele Casadei, Jonah Larkins-Ford, Terence I Moy, James Garner, John B Bremner, Frederick M Ausubel, Kim Lewis, and Michael J Kelso. 2010. “Berberine-INF55 (5-Nitro-2-Phenylindole) Hybrid Antimicrobials: Effects of Varying the Relative Orientation of the Berberine and INF55 Components.” Antimicrobial Agents and Chemotherapy 54 (8): 3219–24. doi:10.1128/AAC.01715-09.